About Christopher Thanos
Form D filings for Actym Therapeutics from 2020 to 2023 list Christopher Thanos as chief executive officer and director.
Christopher Thanos first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Thanos in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Thanos works with at each company, as listed on that company's latest Form D.
Actym Therapeutics, Inc. · Form D, Jul 6, 2023